Dr. Price is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
- Mayo Clinic College of MedicineClass of 2003
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MN State Medical License 2004 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins
Journal of the National Comprehensive Cancer Network. 2025-02-01 - 3 citationsCancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake.Michael F Armstrong, Brian J Burkett, Thomas J O'Byrne, Harrison C Gottlich, Linda X Yin
JAMA Otolaryngology-- Head & Neck Surgery. 2024-12-01 - 1 citationsMulticenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03
Authored Content
- Salivary Gland Cancer Research Got a Boost at ASCOJune 2019
- Salivary Gland Cancer Research Got a Boost at ASCOJune 2019
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- Join now to see all
Press Mentions
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 26th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: